These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 24846288)
1. Immunization of rabbits with highly purified, soluble, trimeric human immunodeficiency virus type 1 envelope glycoprotein induces a vigorous B cell response and broadly cross-reactive neutralization. Quinnan GV; Onabajo O; Zhang P; Yan L; Mattapallil JJ; Zhang Z; Dong M; Lu M; Montefiori D; LaBranche C; Broder CC PLoS One; 2014; 9(5):e98060. PubMed ID: 24846288 [TBL] [Abstract][Full Text] [Related]
2. Effect of trimerization motifs on quaternary structure, antigenicity, and immunogenicity of a noncleavable HIV-1 gp140 envelope glycoprotein. Du SX; Idiart RJ; Mariano EB; Chen H; Jiang P; Xu L; Ostrow KM; Wrin T; Phung P; Binley JM; Petropoulos CJ; Ballantyne JA; Whalen RG Virology; 2009 Dec; 395(1):33-44. PubMed ID: 19815247 [TBL] [Abstract][Full Text] [Related]
3. Elicitation of neutralizing antibodies directed against CD4-induced epitope(s) using a CD4 mimetic cross-linked to a HIV-1 envelope glycoprotein. Dey AK; Burke B; Sun Y; Sirokman K; Nandi A; Hartog K; Lian Y; Geonnotti AR; Montefiori D; Franti M; Martin G; Carfi A; Kessler P; Martin L; Srivastava IK; Barnett SW PLoS One; 2012; 7(1):e30233. PubMed ID: 22291921 [TBL] [Abstract][Full Text] [Related]
13. Conformational States of a Soluble, Uncleaved HIV-1 Envelope Trimer. Liu Y; Pan J; Cai Y; Grigorieff N; Harrison SC; Chen B J Virol; 2017 May; 91(10):. PubMed ID: 28250125 [TBL] [Abstract][Full Text] [Related]
14. Focused dampening of antibody response to the immunodominant variable loops by engineered soluble gp140. Selvarajah S; Puffer BA; Lee FH; Zhu P; Li Y; Wyatt R; Roux KH; Doms RW; Burton DR AIDS Res Hum Retroviruses; 2008 Feb; 24(2):301-14. PubMed ID: 18284327 [TBL] [Abstract][Full Text] [Related]
15. Targeting HIV-1 envelope glycoprotein trimers to B cells by using APRIL improves antibody responses. Melchers M; Bontjer I; Tong T; Chung NP; Klasse PJ; Eggink D; Montefiori DC; Gentile M; Cerutti A; Olson WC; Berkhout B; Binley JM; Moore JP; Sanders RW J Virol; 2012 Mar; 86(5):2488-500. PubMed ID: 22205734 [TBL] [Abstract][Full Text] [Related]
16. A comparative immunogenicity study in rabbits of disulfide-stabilized, proteolytically cleaved, soluble trimeric human immunodeficiency virus type 1 gp140, trimeric cleavage-defective gp140 and monomeric gp120. Beddows S; Franti M; Dey AK; Kirschner M; Iyer SP; Fisch DC; Ketas T; Yuste E; Desrosiers RC; Klasse PJ; Maddon PJ; Olson WC; Moore JP Virology; 2007 Apr; 360(2):329-40. PubMed ID: 17126869 [TBL] [Abstract][Full Text] [Related]
17. The Glycan Hole Area of HIV-1 Envelope Trimers Contributes Prominently to the Induction of Autologous Neutralization. Schorcht A; Cottrell CA; Pugach P; Ringe RP; Han AX; Allen JD; van den Kerkhof TLGM; Seabright GE; Schermer EE; Ketas TJ; Burger JA; van Schooten J; LaBranche CC; Ozorowski G; de Val N; Bader DLV; Schuitemaker H; Russell CA; Montefiori DC; van Gils MJ; Crispin M; Klasse PJ; Ward AB; Moore JP; Sanders RW J Virol; 2022 Jan; 96(1):e0155221. PubMed ID: 34669426 [TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of a broadly cross-reactive HIV-1 human monoclonal antibody that binds to both gp120 and gp41. Zhang MY; Yuan T; Li J; Rosa Borges A; Watkins JD; Guenaga J; Yang Z; Wang Y; Wilson R; Li Y; Polonis VR; Pincus SH; Ruprecht RM; Dimitrov DS PLoS One; 2012; 7(9):e44241. PubMed ID: 22970187 [TBL] [Abstract][Full Text] [Related]